Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

Summary

This pilot phase I trial studies how well sonazoid-enhanced ultrasound works in detecting sentinel lymph node in patients with cutaneous melanoma. Sonazoid is a contrast agent that may make it easier to see if the tumor cells have spread to the sentinel lymph node using an ultrasound.

Timeline

Start

2017-04-26

Primary completion

2019-06-28

Completion

2020-01-09

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient accrual”

Drugs

Indications